GO:0050664 oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0050664 describes a molecular function in which NADH or NADPH donates electrons to molecular oxygen, reducing it to water or reactive oxygen species.
This activity is carried out by flavoenzymes and other redox proteins that contain FMN, FAD, or heme cofactors.
In plants, NAD(P)H-dependent oxygen reduction is linked to carotenoid desaturation in chromoplast membranes.
The term is distinct from NADH oxidase (GO:0003954) and NADPH oxidase (GO:0016175) because it covers both NADH and NADPH as electron donors.
Dysregulation of this activity can alter cellular redox balance and contribute to oxidative stress-related diseases.
CRISPR knockout, point-mutation, and overexpression models are essential to dissect the physiological roles of these enzymes.

Description

GO:0050664, oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor, is a molecular function defined by the catalysis of a redox reaction in which NADH or NADPH serves as the electron donor and molecular oxygen is the electron acceptor. This activity is fundamental to cellular respiration, oxidative stress responses, and various biosynthetic pathways. Enzymes with this activity are found across all kingdoms of life and often utilize flavin or heme cofactors to transfer electrons from NAD(P)H to oxygen. In plants, a 23-kDa oxygen-evolving-complex-like protein is involved in a respiratory redox pathway that links NAD(P)H oxidation to carotene desaturation in chromoplast membranes. Understanding this activity is crucial for researchers studying energy metabolism, antioxidant defense, and the mechanisms of diseases linked to redox imbalance.

oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor At A Glance

GO ID GO:0050664
GO term oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor
Ontology molecular_function
Synonym oxidoreductase activity, acting on NADH or NADPH, oxygen as acceptor
Definition Catalysis of an oxidation-reduction (redox) reaction in which NADH or NADPH acts as a hydrogen or electron donor and reduces an oxygen molecule.
Major function Electron transfer from NAD(P)H to O2, often producing water or reactive oxygen species.
Cofactors FMN, FAD, heme, or other redox-active prosthetic groups.
Subcellular location Cytosol, mitochondria, plastids, and membranes.
Representative enzymes NADH(NADPH)-cytochrome c reductase (FMN-containing), oxygen-evolving-complex-like proteins.

What Is GO:0050664?

This GO term describes the catalytic activity of an enzyme that transfers electrons from either NADH or NADPH to molecular oxygen (O2), reducing it. The reaction typically produces water (H2O) or, in some cases, superoxide or hydrogen peroxide, depending on the enzyme. The definition explicitly states that NADH or NADPH acts as the hydrogen or electron donor, and oxygen is the acceptor. This activity is classified under oxidoreductases and is distinguished from similar terms by its broad specificity for both NADH and NADPH.

Why Is oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor Important in Cell Biology?

This activity is central to cellular redox homeostasis, energy production, and the response to oxidative stress. By transferring electrons from NAD(P)H to oxygen, these enzymes help maintain the balance of reducing equivalents and can generate signaling molecules such as reactive oxygen species (ROS). In plants, the activity is linked to carotenoid biosynthesis, which is vital for photosynthesis and photoprotection. In humans, related enzymes are implicated in cancer, neurodegeneration, and metabolic disorders. Thus, studying GO:0050664 provides insights into fundamental biology and potential therapeutic targets.
Maintains cellular redox balance by oxidizing NAD(P)H and reducing oxygen.
Contributes to the generation of reactive oxygen species (ROS) for signaling and defense.
Plays a role in plant carotenoid desaturation and chromoplast development.
Involved in mitochondrial respiration and energy metabolism.
Dysregulation can lead to oxidative stress, linked to cancer and neurodegeneration.
Provides targets for antioxidant therapies and metabolic engineering.
Enzymes with this activity are used in biotechnological applications, such as biosensors.
Essential for understanding host-pathogen interactions where ROS is used as a defense mechanism.

What Happens During oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor?

Electron Transfer from NAD(P)H to the Enzyme
In simple terms: The enzyme grabs electrons from NADH or NADPH.
The catalytic cycle begins when NADH or NADPH binds to the enzyme's active site. The reduced nicotinamide ring donates a hydride ion (two electrons and a proton) to the enzyme's prosthetic group, such as FMN or FAD. This step is often rate-limiting and can be regulated by substrate availability.
Reduction of Molecular Oxygen
In simple terms: The enzyme passes the electrons to oxygen, turning it into water or other molecules.
The reduced cofactor then transfers electrons to molecular oxygen. Depending on the enzyme, oxygen can be fully reduced to water (four-electron reduction) or partially reduced to superoxide or hydrogen peroxide (one- or two-electron reduction). This step is critical for determining the product and the potential for ROS generation.
Cofactor Regeneration and Product Release
In simple terms: The enzyme resets itself to start the cycle again.
After oxygen reduction, the enzyme's cofactor returns to its oxidized state, and the products (water or ROS) are released. The enzyme is then ready for another round of catalysis. The overall reaction is: NAD(P)H + H+ + O2 -> NAD(P)+ + H2O (or ROS). The stoichiometry and kinetics vary among enzymes.
Coupling to Cellular Processes
In simple terms: This activity is connected to other cellular jobs, like making pigments.
In plants, the redox activity is coupled to carotene desaturation in chromoplast membranes, where a 23-kDa oxygen-evolving-complex-like protein participates in a respiratory redox pathway. This illustrates how the activity can be integrated into biosynthetic pathways beyond simple detoxification.

Key Genes Involved in GO:0050664 oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor

The following genes and proteins are representative of those that exhibit or are associated with oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor.
GeneMajor RoleResearch Relevance
CYB5R3NADH-cytochrome b5 reductaseInvolved in fatty acid desaturation and drug metabolism
NDI1Internal NADH dehydrogenaseMitochondrial respiration and ROS production
AOX1Alternative oxidasePlant and fungal respiration, bypasses cytochrome pathway
NOX1NADPH oxidase 1ROS generation in signaling and host defense
NOX2NADPH oxidase 2Phagocyte oxidative burst
NOX4NADPH oxidase 4Constitutive ROS production, fibrosis
NOX5NADPH oxidase 5Calcium-dependent ROS generation
DUOX1Dual oxidase 1Thyroid hormone synthesis and mucosal defense
DUOX2Dual oxidase 2Thyroid hormone synthesis
NQO1NAD(P)H quinone dehydrogenase 1Detoxification and antioxidant defense
PORCytochrome P450 oxidoreductaseElectron transfer to P450 enzymes
FDX1Ferredoxin 1Electron transfer in mitochondria
CYPORCytochrome P450 oxidoreductaseDrug metabolism and steroidogenesis
MICAL1Microtubule associated monooxygenaseActin dynamics and redox signaling
MICAL2Microtubule associated monooxygenaseActin dynamics and redox signaling
MSRAMethionine sulfoxide reductase ARepair of oxidized methionine
MSRB1Methionine sulfoxide reductase B1Repair of oxidized methionine

How Is oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor Regulated?

The activity of enzymes with GO:0050664 is regulated at multiple levels. Transcriptional regulation controls enzyme abundance in response to oxidative stress, hypoxia, and metabolic demands. Post-translational modifications, such as phosphorylation, can modulate catalytic efficiency. Allosteric regulation by NAD(P)H/NAD(P)+ ratios and feedback inhibition by products (e.g., ROS) fine-tunes activity. In plants, the 23-kDa oxygen-evolving-complex-like protein is regulated by developmental and environmental cues. Additionally, cofactor availability (FMN, FAD, heme) and subcellular localization influence overall activity.

oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor and Human Disease

GeneDisease / BiologyPotential Experimental Model
NOX1Colorectal cancerKnockout in HCT116 cells
NOX2Chronic granulomatous diseasePoint mutation in PLB-985 cells
NOX4Pulmonary fibrosisOverexpression in A549 cells
NQO1Cancer chemoresistanceKnockout in MCF-7 cells
MSRANeurodegenerationKnock-in in SH-SY5Y cells
Cancer
Altered expression of NAD(P)H oxidases and related enzymes can lead to increased ROS production, promoting genomic instability, proliferation, and survival. For example, NOX1 and NOX4 are overexpressed in various cancers and contribute to tumorigenesis. Targeting these enzymes with inhibitors or CRISPR knockout is a promising therapeutic strategy.
Neurodegeneration
Oxidative stress is a hallmark of neurodegenerative diseases such as Alzheimer's and Parkinson's. Dysregulated NAD(P)H-dependent oxygen reduction can exacerbate ROS accumulation, leading to neuronal damage. Enzymes like NQO1 and MSRA play protective roles, and their dysfunction is linked to disease progression.
Metabolic Disorders
Redox imbalance contributes to insulin resistance, obesity, and cardiovascular diseases. NADPH oxidases are implicated in endothelial dysfunction and inflammation. Modulating their activity through genetic models can elucidate their roles in metabolic syndrome.
Infectious Diseases
Phagocytic NOX2 generates ROS to kill pathogens. Defects in NOX2 cause chronic granulomatous disease, characterized by recurrent infections. Studying this activity helps understand host-pathogen interactions and develop immunotherapies.

From oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor-Related Genes to Experimental Models

Research QuestionSuitable Model
Does loss of NOX1 reduce ROS and tumor growth?NOX1 knockout in cancer cell lines
Does a specific NOX2 mutation impair phagocyte function?Point mutation knock-in in iPSCs
Can overexpression of NQO1 protect against oxidative stress?NQO1 overexpression in neuronal cells
What is the subcellular localization of AOX1?Tagged knock-in with GFP in plant cells
Is the 23-kDa protein essential for carotene desaturation?Knockout in Narcissus pseudonarcissus chromoplasts
Does NOX4 inhibition reverse fibrosis?Inducible knockout in mouse models

How to Study the oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor Process

MethodWhat It MeasuresTypical Application
NAD(P)H oxidation assayEnzyme kineticsPurified enzyme characterization
Oxygen consumption assayO2 consumption rateMitochondrial respiration
Amplex RedH2O2 productionCellular ROS detection
DCFDATotal ROSHigh-throughput screening
CRISPR knockoutGene functionLoss-of-function studies
RNA-seqTranscriptional changesPathway analysis
Redox proteomicsOxidized proteinsBiomarker discovery
Enzymatic Activity Assays
Spectrophotometric assays monitor the oxidation of NAD(P)H at 340 nm or the reduction of oxygen using oxygen electrodes. These methods provide kinetic parameters (Km, Vmax) and are essential for characterizing enzymes with GO:0050664.
ROS Detection
Fluorescent probes such as DCFDA, Amplex Red, and MitoSOX measure ROS production in live cells. These assays link enzyme activity to cellular oxidative stress and signaling.
Genetic Knockout and Knockdown
CRISPR/Cas9 knockout or siRNA knockdown of candidate genes followed by phenotypic analysis (e.g., proliferation, ROS levels) helps establish causality. This is particularly useful for distinguishing among NOX family members.
Proteomics and Redox Proteomics
Mass spectrometry-based approaches identify oxidized proteins and post-translational modifications, revealing downstream effects of NAD(P)H-dependent oxygen reduction.

How CRISPR Can Be Used to Study GO:0050664 oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor

Knockout

CRISPR knockout of genes encoding GO:0050664 enzymes (e.g., NOX1, NOX4) abolishes their activity, allowing researchers to study loss-of-function phenotypes such as reduced ROS production, altered cell proliferation, or metabolic reprogramming. This approach is ideal for validating drug targets.

Point Mutation

Introducing specific point mutations (e.g., in the NADPH binding site of NOX2) via CRISPR base editing or HDR can mimic disease-associated variants or dissect catalytic residues. These models help understand structure-function relationships and drug resistance.

Knock-in

Knock-in of tagged versions (e.g., GFP, HA) of these enzymes enables real-time imaging of localization and interaction partners. Knock-in of disease mutations (e.g., in NQO1) creates isogenic models for drug testing.

Overexpression

CRISPR activation (CRISPRa) or lentiviral overexpression of these enzymes increases their activity, useful for studying gain-of-function effects, ROS-mediated signaling, and protection against oxidative stress.

How EDITGENE Supports oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor Research

Researchers studying oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as ROS production or disease progression. EDITGENE provides a comprehensive suite of CRISPR services to create precisely engineered cell models, enabling rigorous functional studies.
Contact EDITGENE today to design your custom CRISPR model for oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor research.

Frequently Asked Questions About oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor

GO:0050664 is a Gene Ontology molecular function term for oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor. It describes enzymes that transfer electrons from NADH or NADPH to molecular oxygen.
Genes include NOX1, NOX2, NOX4, NQO1, CYB5R3, AOX1, and others that encode enzymes with this activity.
GO:0050664 encompasses both NADH and NADPH as electron donors, whereas NADH oxidase (GO:0003954) is specific to NADH.
It is measured using spectrophotometric NAD(P)H oxidation assays, oxygen consumption assays, or ROS detection probes.
Diseases include cancer, neurodegeneration, chronic granulomatous disease, and metabolic disorders, often due to ROS imbalance.
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this context.
Common cofactors include FMN, FAD, and heme, which facilitate electron transfer from NAD(P)H to oxygen.
Yes, a 23-kDa oxygen-evolving-complex-like protein in Narcissus pseudonarcissus chromoplasts is involved in a respiratory redox pathway linked to carotene desaturation.
It can promote ROS generation, leading to genomic instability and tumor progression; NOX1 and NOX4 are often overexpressed in cancers.
EDITGENE provides custom CRISPR cell models, library screening, and bioinformatics to study genes with this activity.

Conclusion

GO:0050664 represents a fundamental molecular function that bridges cellular metabolism, redox signaling, and disease. By understanding the enzymes and pathways involved, researchers can develop targeted therapies for oxidative stress-related conditions. CRISPR-based models are indispensable for dissecting these mechanisms, and EDITGENE offers the tools to accelerate discovery.

References

  1. 1. Johnson MS et al.. 1986. Studies on NADH(NADPH)-cytochrome c reductase (FMN-containing) from yeast: steady-state kinetic properties of the flavoenzyme from top-fermenting ale yeast.. Arch Biochem Biophys 245(1):271-81 PMID: 3080958
  2. 2. Nievelstein V et al.. 1995. Carotene desaturation is linked to a respiratory redox pathway in Narcissus pseudonarcissus chromoplast membranes. Involvement of a 23-kDa oxygen-evolving-complex-like protein.. Eur J Biochem 233(3):864-72 PMID: 8521852
Contact Us
*
*
*
*
How did you hear about us: